These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 31538903
1. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma. Liu Y, Li Z, Tang X, Li M, Shi F. Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903 [Abstract] [Full Text] [Related]
2. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma. Liu Y, Shi F. Eur J Cancer Prev; 2020 May; 29(3):259-265. PubMed ID: 31651569 [Abstract] [Full Text] [Related]
3. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC). Li JJ, Zheng PCJ, Wang YZ. World J Surg Oncol; 2017 Jun 06; 15(1):114. PubMed ID: 28587656 [Abstract] [Full Text] [Related]
4. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer. Gong L, Xu Y, Hu YQ, Ding QJ, Yi CH, Huang W, Zhou M. Cancer Biomark; 2016 Jul 08; 17(2):195-204. PubMed ID: 27472887 [Abstract] [Full Text] [Related]
5. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma. Ge M, Shi M, An C, Yang W, Nie X, Zhang J, Lv Z, Li J, Zhou L, Du Z, Yang M. Sci Rep; 2016 May 17; 6():26037. PubMed ID: 27185198 [Abstract] [Full Text] [Related]
6. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study. Bayram S, Ülger Y, Sümbül AT, Kaya BY, Genç A, Rencüzoğullari E, Dadaş E. Gene; 2016 Jul 01; 585(1):84-92. PubMed ID: 27016301 [Abstract] [Full Text] [Related]
7. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology. de Martino M, Taus C, Lucca I, Hofbauer SL, Haitel A, Shariat SF, Klatte T. Mol Carcinog; 2016 Oct 01; 55(10):1458-66. PubMed ID: 26294352 [Abstract] [Full Text] [Related]
8. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population. Zhang J, Ju H, Gao JR, Jiao XL, Lu Y. Oncotarget; 2017 Mar 21; 8(12):20235-20243. PubMed ID: 28423629 [Abstract] [Full Text] [Related]
10. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population. Jin M, Li Z, Sun Y, Zhang M, Chen X, Zhao H, Yu Q. Int J Med Sci; 2021 Mar 21; 18(2):441-447. PubMed ID: 33390813 [Abstract] [Full Text] [Related]
11. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma. Hirokawa T, Arimasu Y, Chiba T, Fujiwara M, Kamma H. Pathol Int; 2020 Apr 21; 70(4):217-223. PubMed ID: 31943527 [Abstract] [Full Text] [Related]
12. Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases. Mervic A, Goricar K, Blagus T, Franko A, Trebusak-Podkrajsek K, Fikfak MD, Dolzan V, Kovac V. Radiol Oncol; 2024 Mar 01; 58(1):87-98. PubMed ID: 38378028 [Abstract] [Full Text] [Related]
13. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population. Duffek M, Skerenova M, Halasova E, Sarlinova M, Dzian A, Repiska V, Dobrovodsky A, Mistuna D, Bernadic M, Matakova T. Bratisl Lek Listy; 2022 Mar 01; 123(7):475-48. PubMed ID: 35907052 [Abstract] [Full Text] [Related]
14. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population. Yuan K, Huo M, Sun Y, Wu H, Chen H, Wang Y, Fu R. Tumour Biol; 2016 Jan 01; 37(1):979-87. PubMed ID: 26264616 [Abstract] [Full Text] [Related]
15. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features. Heidari Z, Harati-Sadegh M, Arian A, Maruei-Milan R, Salimi S. IUBMB Life; 2020 May 01; 72(5):922-930. PubMed ID: 31895498 [Abstract] [Full Text] [Related]
17. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma. Jendrzejewski J, Liyanarachchi S, Eiterman A, Thomas A, He H, Nagy R, Senter L, Sworczak K, de la Chapelle A. Int J Cancer; 2019 Feb 01; 144(3):503-512. PubMed ID: 30350351 [Abstract] [Full Text] [Related]
18. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer. Bu R, Siraj AK, Divya SP, Kong Y, Parvathareddy SK, Al-Rasheed M, Al-Obaisi KAS, Victoria IG, Al-Sobhi SS, Al-Dawish M, Al-Dayel F, Al-Kuraya KS. Int J Cancer; 2018 May 15; 142(10):2028-2039. PubMed ID: 29266240 [Abstract] [Full Text] [Related]
19. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, Wang Y, Wang X, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC. J Med Genet; 2013 Oct 15; 50(10):689-95. PubMed ID: 23847140 [Abstract] [Full Text] [Related]
20. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. Chou SJ, Chen CM, Harn HJ, Chen CJ, Liu YC. J Surg Res; 2001 Jul 15; 99(1):75-83. PubMed ID: 11421607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]